STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. CPSR

Calamos S&P 500 Str Alt Prt ETF-Mar Stock Price, News & Analysis

CPSR NYSE

Company Description

Welcome to the overview page for Calamos S&P 500 Str Alt Prt ETF-Mar (CPSR), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

Chart
$25.02
-0.01%
0.00
Last updated: November 29, 2025 at 11:30
5.46 %
Performance 1 year
$0.0
Market Cap
900.0K
Shares outstanding

Latest News

View All
May 4, 2022
0.00%

PureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022

clinical trial
April 29, 2022
0.00%

PureTech Founded Entity Gelesis Announces its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study

April 26, 2022
0.00%

PureTech Announces Annual Results for Year Ended December 31, 2021

January 14, 2022
0.00%

PureTech Founded Entity Gelesis, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with Capstar

January 13, 2022
222.44%

Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of Its Business Combination with Capstar

January 5, 2022
0.10%

Gelesis Adds Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee

management

SEC Filings

View All

No SEC filings available for Calamos S&P 500 Str Alt Prt ETF-Mar.

Financial Highlights

$0
Revenue (TTM)
$12,898,082
Net Income (TTM)
-$446,644
Operating Cash Flow
0.00
Current Ratio
-$20,674,209
Operating Income
—
Diluted EPS (TTM)

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Calamos S&P 500 Str Alt Prt ETF-Mar (CPSR)?

The current stock price of Calamos S&P 500 Str Alt Prt ETF-Mar (CPSR) is $25.0274 as of November 28, 2025.

What is the revenue (TTM) of Calamos S&P 500 Str Alt Prt ETF-Mar (CPSR) stock?

The trailing twelve months (TTM) revenue of Calamos S&P 500 Str Alt Prt ETF-Mar (CPSR) is $0.

What is the net income of Calamos S&P 500 Str Alt Prt ETF-Mar (CPSR)?

The trailing twelve months (TTM) net income of Calamos S&P 500 Str Alt Prt ETF-Mar (CPSR) is $12,898,082.

What is the operating cash flow of Calamos S&P 500 Str Alt Prt ETF-Mar (CPSR)?

The operating cash flow of Calamos S&P 500 Str Alt Prt ETF-Mar (CPSR) is -$446,644. Learn about cash flow.

What is the current ratio of Calamos S&P 500 Str Alt Prt ETF-Mar (CPSR)?

The current ratio of Calamos S&P 500 Str Alt Prt ETF-Mar (CPSR) is 0.00, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Calamos S&P 500 Str Alt Prt ETF-Mar (CPSR)?

The operating income of Calamos S&P 500 Str Alt Prt ETF-Mar (CPSR) is -$20,674,209. Learn about operating income.